Stay updated on OMS721 in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.

Latest updates to the OMS721 in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedDifference0.4%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.5%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant updates regarding the clinical trial for OMS721 in IgA Nephropathy, including the removal of detailed study objectives and criteria, while retaining the core information about patient randomization and the trial's revision number.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to OMS721 in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.